Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxenda for Weight Regain After RYGB
NCT03048578Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- May 2017
- Primary completion
- Mar 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, sponsored by NYU Langone Health. Started May 2017; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03048578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03048578.